M. Franco G. Salvoza

Array ( [id] => 6228817 [patent_doc_number] => 20100183555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHODS AND KITS FOR DETERMINING DRUG SENSITIVITY IN PATIENTS INFECTED WITH HCV' [patent_app_type] => utility [patent_app_number] => 12/525944 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13074 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183555.pdf [firstpage_image] =>[orig_patent_app_number] => 12525944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10083511 [patent_doc_number] => 09120849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Nucleic acid amplification controls' [patent_app_type] => utility [patent_app_number] => 11/929089 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10474 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11929089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090234 [patent_doc_number] => 09127048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Nucleic acid amplification controls' [patent_app_type] => utility [patent_app_number] => 11/929123 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10323 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11929123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095395 [patent_doc_number] => 20110002955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'ANTI-OBESE IMMUNOGENIC HYBRID POLYPEPTIDES AND ANTI-OBESE VACCINE COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/442760 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10686 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002955.pdf [firstpage_image] =>[orig_patent_app_number] => 12442760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367071 [patent_doc_number] => 20090304630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Treating severe and acute viral infections' [patent_app_type] => utility [patent_app_number] => 11/882532 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4360 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304630.pdf [firstpage_image] =>[orig_patent_app_number] => 11882532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046780 [patent_doc_number] => 20110206711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHOD FOR INDUCING CYTOTOXIC T-CELLS, CYTOTOXIC T-CELL INDUCER, AND PHARMACEUTICAL COMPOSITION AND VACCINE EMPLOYING SAME' [patent_app_type] => utility [patent_app_number] => 12/279556 [patent_app_country] => US [patent_app_date] => 2007-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7040 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206711.pdf [firstpage_image] =>[orig_patent_app_number] => 12279556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337326 [patent_doc_number] => 20090053790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Polypeptide Having Affinity for Envelope Virus Constituent and Use Thereof in Transferring Substance Into Cell' [patent_app_type] => utility [patent_app_number] => 12/223464 [patent_app_country] => US [patent_app_date] => 2007-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16102 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053790.pdf [firstpage_image] =>[orig_patent_app_number] => 12223464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10082480 [patent_doc_number] => 09119810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Compositions and vaccines against influenza A and influenza B infections' [patent_app_type] => utility [patent_app_number] => 12/094114 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8840 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12094114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11636261 [patent_doc_number] => 09658224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-23 [patent_title] => 'Phage particle diagnostic reagents' [patent_app_type] => utility [patent_app_number] => 12/085618 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 24808 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12085618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367170 [patent_doc_number] => 20090304729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'CELL-DERIVED VIRAL VACCINES WITH LOW LEVELS OF RESIDUAL CELL DNA' [patent_app_type] => utility [patent_app_number] => 12/092190 [patent_app_country] => US [patent_app_date] => 2006-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12703 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304729.pdf [firstpage_image] =>[orig_patent_app_number] => 12092190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5216013 [patent_doc_number] => 20070105094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'WATER-SOLUBLE CATIONIC MAGNETIC FINE PARTICLES AND METHOD FOR SEPARATING OR DETECTING LIPID VESICLE USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/551365 [patent_app_country] => US [patent_app_date] => 2006-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15518 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105094.pdf [firstpage_image] =>[orig_patent_app_number] => 11551365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014926 [patent_doc_number] => 20110223197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Mucosal and Systemic Immunization with Alphavirus Replicon Particles' [patent_app_type] => utility [patent_app_number] => 12/083906 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28416 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223197.pdf [firstpage_image] =>[orig_patent_app_number] => 12083906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791613 [patent_doc_number] => 20080292586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Method and Use of Interferon Compositions For the Treatment of Avian Influenza' [patent_app_type] => utility [patent_app_number] => 11/883588 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10145 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292586.pdf [firstpage_image] =>[orig_patent_app_number] => 11883588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219694 [patent_doc_number] => 20070161005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'CULTURING CIRCULAR SSDNA VIRUSES FOR THE PRODUCTION OF VACCINES' [patent_app_type] => utility [patent_app_number] => 11/275842 [patent_app_country] => US [patent_app_date] => 2006-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9601 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161005.pdf [firstpage_image] =>[orig_patent_app_number] => 11275842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285668 [patent_doc_number] => 20090099343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Isolation of pathogenic prions' [patent_app_type] => utility [patent_app_number] => 11/795165 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26330 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099343.pdf [firstpage_image] =>[orig_patent_app_number] => 11795165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843484 [patent_doc_number] => 20060121604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Methods and materials for expression of a recombinant protein' [patent_app_type] => utility [patent_app_number] => 11/295006 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11826 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121604.pdf [firstpage_image] =>[orig_patent_app_number] => 11295006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 455702 [patent_doc_number] => 07244432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Infectious bursal disease virus (IBDV) variant from Georgia' [patent_app_type] => utility [patent_app_number] => 11/170056 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12032 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244432.pdf [firstpage_image] =>[orig_patent_app_number] => 11170056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 533204 [patent_doc_number] => 07172862 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'FBL2-specific agents as modulators of Flaviviridae RNA replication' [patent_app_type] => utility [patent_app_number] => 11/122373 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/172/07172862.pdf [firstpage_image] =>[orig_patent_app_number] => 11122373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 641492 [patent_doc_number] => 07122191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Microfluidized oil-in-water emulsions and vaccine compositions' [patent_app_type] => utility [patent_app_number] => 11/096831 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 16176 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122191.pdf [firstpage_image] =>[orig_patent_app_number] => 11096831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 899260 [patent_doc_number] => 07338661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-04 [patent_title] => 'Infectious bursal disease virus antigenic isolates and vaccines' [patent_app_type] => utility [patent_app_number] => 11/076713 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6840 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/338/07338661.pdf [firstpage_image] =>[orig_patent_app_number] => 11076713 [rel_patent_id] =>[rel_patent_doc_number] =>)